ZECHENG ELECTRONICS
837821
Ji Yao Holding Group
300108
Shenzhen Bestek Technology
300822
Jiangsu Canlon Building Materials
300715
Shanghai Hajime Advanced Material Technology
301000
CN Stock MarketDetailed Quotes
002550 Changzhou Qianhong Biopharma
- 5.88
- -0.11-1.84%
Not Open Jan 9 15:00 CST
7.53BMarket Cap25.68P/E (TTM)
6.01High5.85Low113.39KlotVolume5.95Open5.99Pre Close67.25MTurnover1.25%Turnover Ratio41.41P/E (Static)1.28BShares7.1852wk High3.04P/B5.35BFloat Cap4.0852wk Low6.59Limit Up910.23MShs Float15.99Historical High5.39Limit Down2.67%Amplitude0.85Historical Low0.12Dividend TTM5.93Avg Price62.56KlotAsk2.04%Div YieldTTM100Lot Size48.48KlotBid
Changzhou Qianhong Biopharma News
Qianhong Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Qianhong Pharmaceutical: Legal Opinion of the Third Extraordinary General Meeting of Shareholders in 2024
Qianhong Pharmaceutical: Prompt Announcement on Convening the Third Extraordinary General Meeting of Shareholders in 2024
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Corrected Notice Concerning the Notice of Convening the Third Extraordinary General Meeting of Shareholders in 2024
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Notice on the Notice of Convening the Third Extraordinary General Meeting of Shareholders in 2024
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Prompt Notice on Disclosure of Plans to Issue Convertible Corporate Bonds to Unspecified Targets
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Announcement of Resolutions of the 7th Meeting of the 6th Board of Directors
Qianhong Pharmaceuticals: Qianhong Pharmaceuticals: Convertible Corporate Bondholders\' Meeting Rules
Qianhong Pharmaceutical: 2024-049 Qianhong Pharmaceutical: Announcement on Issuance of Convertible Corporate Bonds to Unspecified Targets, Diluted Immediate Returns and Compensation Measures and Related Entity Commitments
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Announcement of Resolutions of the First Meeting of the 6th Special Meeting of Independent Directors
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Demonstration Analysis Report on Issuance of Convertible Corporate Bonds Issuance Plan to Unspecified Targets
Qianhong Pharmaceutical: 2024-047 Qianhong Pharmaceutical: Plan to issue convertible corporate bonds to unspecified targets
Qianhong Pharmaceutical: Shareholders\' Meeting Proceedings Compilation
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Announcement on the need to issue a report on the use of funds raised previously
Qianhong Pharmaceuticals: Qianhong Pharmaceuticals: Shareholder Return Plan for the Next Three Years (2024-2026)
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Feasibility Analysis Report on the Use of Funds Raised by Issuing Convertible Corporate Bonds to Unspecified Targets
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Notice on not being penalized or taken regulatory measures by the securities regulatory authorities or the stock exchange in the last five years
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Announcement of Resolutions of the Fifth Meeting of the 6th Board of Supervisors
Qianhong Pharmaceuticals: Qianhong Pharmaceuticals: Legal Opinion of the 2024 Second Extraordinary General Meeting of Shareholders
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
